High cholesterol trials recruiting in District of Columbia

All High cholesterol trials nationally

Cities in District of Columbia

Recruiting trials in District of Columbia

• A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
  NCT07058077 · Phase: Phase 2, Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
  NCT06597019 · Phase: Phase 3 · Ages: 6 Years to 11 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
  NCT06597006 · Phase: Phase 3 · Ages: 2 Years to 11 Years · Sex: All (male and female) · District of Columbia: Washington D.C.